A molecular signature of metastasis in primary solid tumors

Nature Genetics

Volumn 33, Issue 1, 2003, Pages 49-54

  Ramaswamy, Sridhar ^a,b   Ross, Ken N ^a   Lander, Eric S ^a,c   Golub, Todd R ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; ARTICLE; CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIATION; DISEASE ASSOCIATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; METASTASIS; MULTIPLE CANCER; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SOLID TUMOR;

ADENOCARCINOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; ORGAN SPECIFICITY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0037226593     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1060     Document Type: Article

References (29)

1. Hellman, S., DeVita, V.T. & Rosenberg, S.A. Cancer: Principles & Practice of Ontology. (Lippincott-Raven, Philadelphia, 2001).
2. Poste, G. & Fidier, I.J. The pathogenesis of cancer metastasis. Nature 283, 139-146 (1980).
3. Fidler, I.J. & Kripke, M.L. Metastasis results from pre-existing variant cells within a malignant tumor. Science 197, 893-895 (1977).
4. Clark, E.A., Golub, T.R., Lander, E.S. & Hynes, R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532-535 (2000).
5. Bhattacharjee, A. et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA 98, 13790-13795 (2001).
6. Schiller, J.H. et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N. Engl. J. Med. 346, 92-98 (2002).
7. van't Veer, L.J. et al. Gene-expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
8. Singh, D. et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1, 203-209 (2002).
9. Pomeroy, S.L. et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415, 436-442 (2002).
10. Shipp, M.A. et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8, 68-74 (2002).
11. Anand, N. et al. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat. Genet. 31, 301-305 (2002).
12. Zou, H., McGarry, T.J., Bernal, T. & Kirschner, M.W. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285, 418-422 (1999).
13. Jallepalli, P.V. et al. Securin is required for chromosomal stability in human cells. Cell 105, 445-457 (2001).
14. Heaney, A.P. et al. Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 355, 716-719 (2000).
15. Bernal, J.A. et al. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat. Genet. 32, 306-311 (2002).
16. Skobe, M. & Fusenig, N.E. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc. Natl. Acad. Sci. USA 95, 1050-1055 (1998).
17. Olumi, A.F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002-5011 (1999).
18. Brown, L.F. et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin. Cancer Res. 5, 1041-1056 (1999).
19. Jensen, B.V., Johansen, J.S., Skovsgaard, T., Brandt, J. & Teisner, B. Extracellular matrix building marked by the N-terminal propeptide of procollagen type I reflect aggressiveness of recurrent breast cancer. Int. J. Cancer 98, 582-589 (2002).
20. Pardoll, D.M. Spinning molecular immunology into successful immunotherapy. Nat. Rev. Immunol. 2, 227-238 (2002).
21. Song, W.J. et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet. 23, 166-175 (1999).
22. Bernards, R. & Weinberg, R.A. Metastasis genes: A progression puzzle, Nature 418, 823 (2002).
23. Braun, S. et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N. Engl. J. Med. 342, 525-533 (2000).
24. Hainsworth, J.D. & Greco, F.A. Treatment of patients with cancer of an unknown primary site. N. Engl. J. Med. 329, 257-263 (1993).
25. Perou, C.M. et al. Molecular portraits of human breast tumours, Nature 406, 747-752 (2000).
26. Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene-expression profiling. Nature 403, 503-511 (2000).
27. Ramaswamy, S. et al. Multiclass cancer diagnosis using tumor gene-expression signatures. Proc. Natl. Acad. Sci. USA 98, 15149-15154 (2001).
28. Golub, T.R. et al. Molecular classification of cancer: Class discovery and class prediction by gene-expression monitoring. Science 286, 531-537 (1999).
29. Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868 (1998).